The European Medical Technology Industry. in figures / 2018

Similar documents
The European Medical Technology Industry in figures

The Innovation Union Scoreboard: Monitoring the innovation performance of the 27 EU Member States

CAP CONTEXT INDICATORS

Over the whole year 2011, GDP increased by 1.4% in the euro area and by 1.5% in the EU27, compared with +1.9% and +2.0% respectively in 2010.

Sea freight data indicate weak import demand both in US and EU27. Data on inland road and rail freight indicate weak domestic activity

International trade related air freight volumes move back above the precrisis level of June 2008 both in the EU area and in the Unites States;

FRAMEWORK CONVENTION ON CLIMATE CHANGE - Secretariat CONVENTION - CADRE SUR LES CHANGEMENTS CLIMATIQUES - Secrétariat KEY GHG DATA

Emissions Trading System (ETS): The UK needs to deliver its share of the total EU ETS emissions reduction of 21% by 2020, compared to 2005;

Session 13: Prequalification Within the Context of Global Fund Procurements

Energy demand dynamics and infrastructure development plans in the EU. October 10 th, 2012 Jonas Akelis, Managing Partner - Baltics

USA and EU27 external trade by sea and by air, measured in tonnes of goods moved, remain stagnant below pre-crisis (June 2008) levels;

Even implementation of the EU Timber Regulation Harmonizing and improving the implementation of the EUTR in the EUTR countries

The Fourth Community Innovation Survey (CIS IV)

Market surveillance of medical devices

High-Level Public Administration Conference For a Business-Friendly Public Administration Brussels, 29 October 2013

ENERGY PRIORITIES FOR EUROPE

Performance of Rural Development Programmes of the period - Your Voice

Surface freight volumes, measured in tonne-kilometres of goods transported, show signs of a slowing down in China and Russia.

Siemens Partner Program

Environmental statistics in Europe Facts and figures on the environment: from environmental taxes to water resources

Example of using detailed statistics: The case of poplar markets in EU

EUROPEAN COUNCIL Brussels, 31 May 2013 (OR. en)

Detailed Data from the 2010 OECD Survey on Public Procurement

12. Waste and material flows

The Community Innovation Survey 2010

CAP CONTEXT INDICATORS

International Indexes of Consumer Prices,

EUROPE S ENERGY PORTAL

Flash Eurobarometer 426. SMEs, Resource Efficiency and Green Markets

Council of the European Union Brussels, 10 November 2016 (OR. en)

Photo: Thinkstock. Wind in power 2010 European statistics. February The European Wind energy association

INNOVATION UNION SCOREBOARD 2011

How to improve collection on organic agriculture in the countries of Central and Eastern Europe

AMBITION OF RENEWABLE ENERGY TARGETS FOR THE EU IN 2030

At A Glance Summary of Q highlights

Wind energy in Europe markets

Eurostat current work on resource-efficient circular economy Renato Marra Campanale

How to secure Europe s competitiveness in terms of energy and raw materials? The answer, my friend, is blowing in the wind

ANNEXES. to the COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL

RFID Systems Radio Country Approvals

Trends in waste generation and management in Europe. Özgür Saki European Environment Agency

ANNUAL PUBLICATION: detailed data. VOLUME OF EXPORTS FELL BY 4,7 PER CENT IN 2015 Export prices rose 0,7 per cent. 24 March 2016

PPI Training. MODULE 2 The need to innovate in municipal waste management. PPI training Location of the training Date of the training.

Air freight volumes in tonnes of goods moved, considered as a lead indicator, have recovered above pre-crisis peak in the United States and EU-28.

Making the Parcel Regulation work. 17th Königswinter Postal Seminar 5-7 February

ESF Ex-Post evaluation

The FMD Pack Coding, Sharing and Transition

Solar Heat Worldwide

Environmental Best Practices, It Begins with Us: Business, Local Governments and International Community Should Work Together

European Pharmaceutical Policy: Access for Patients or Improving Competitiveness

Innovation. Union. Scoreboard Enterprise and Industry

Quality of life indicators - natural and living environment

10. Demand (light road freight veh shares)

Resource efficiency and waste

ASSESSING GOOD PRACTICES IN POLICIES AND MEASURES TO MITIGATE CLIMATE CHANGE IN CENTRAL AND EASTERN EUROPE. Elena Petkova

Background of gas data transparency Gas data collection exercise: questionnaire, methodologies and definitions

Online Appendix: How should we measure environmental policy stringency?

Correlations between energy economy and housing market prices in the EU-impacts on future sustainability

Latest state-of-play EU Timber Regulation. Harmonizing and improving the implementation of the EUTR in the EUTR countries


Figure 1. Energy dependency of EU member states in 2004 (%)

CAP CONTEXT INDICATORS

Munkaanyag

The Pharmaceutical Industry in Figures

Antitrust: Car price report shows price differentials for new cars in EU narrowing in 2010

European Label Industry Continues Dynamic Track Record in 2017

Organic market & trade: what current figures don't say Raffaele Zanoli

Background paper. Electricity production from wind and solar photovoltaic power in the EU

Photo: Karpov. Wind in power 2009 European statistics. February 2010 THE EUROPEAN WIND ENERGY ASSOCIATION

Highlights. Figure 1. World Marketed Energy Consumption by Region,

Cutting Red Tape The Member State point of view. Presentation by Hilde Van de Velde Bruges March 2010

IAB Adex Benchmark 2012 Daniel Knapp, IHS Electronics & Media

Rethinking E-Government Services

.eu brand awareness. Domain names have a high awareness. About 81% of the European Internet population has heard of domain names.

ODYSSEE-MURE, a decision support tool for energy efficiency policy evaluation. Recent energy efficiency trends in the EU

The aim of this paper is to outline how PRO EUROPE and its members participate to these efforts through:

Fare clic per modificare lo stile del sottotitolo dello schema THE BIOTECH SECTOR IN ITALY AND LOMBARDY

QUESTIONNAIRE FOR FIRMS. INNOVATION-BASED STRATEGIES FOR GLOBALIZATION Questionnaire for SECTOR NAME (COUNTRY NAME)

Europe s Number One Medical Diagnostics Provider

This document is a preview generated by EVS

GLOBAL COALITION FOR GOOD WATER GOVERNANCE

This document is a preview generated by EVS

Munkaanyag

Sectoral Profile - Industry

3. Future wood demand for energy

Relating to the transnational hiring-out of workers in the framework of the provision of services

Solution Partner Program Global Perspective

This document is a preview generated by EVS

This document is a preview generated by EVS

Digital Transformation on Ports, Transport and Logistics EURO MED TELCO FORUM 2016

This document is a preview generated by EVS

Outlook on WtE bottom ash recycling and EU policy

International Business Parcels Rate card

GRI Sustainability Reporting Statistics Publication year By Report Services

Circular Economy and Energy Union

That s Thuringia. Dinner Seminar in Akron / Ohio. on October 2, 2013

Cancer survival trends and inequalities: what is the role for Europe?

A decade of oil demand

Contribution of Forest Management Credits in Kyoto Protocol Compliance and Future Perspectives

Energy Statistics 2017 edition

Transcription:

The European Medical Technology Industry in figures / 2018

Table of contents What is Medical Technology? 4 Innovation 10 Employment 14 Companies 18

Expenditure on Medical Technology 20 MedTech Market in Europe 24 Trade in Europe 32 About MedTech Europe 38

What is Medical Technology?

Medical technology is any technology used to save lives or transform the health of individuals suffering from a wide range of conditions. In its many forms, medical technology is already diagnosing, monitoring and treating virtually every disease or condition that affects us. For the sake of this document, medical technology includes medical devices and in vitro diagnostic medical devices. Medical devices are products intended to perform a therapeutic or diagnostic action on human beings by physical means. In vitro diagnostic medical devices are products which provide medically useful diagnostic information by examination of a specimen derived from the human body. What is Medical Technology? 5

There are more than 500,000 medical technologies currently available and they all share a common purpose: improving, extending and transforming people s lives. Medical technology can be familiar, everyday products such as blood glucose meters, sticking plasters, syringes or latex gloves. Alternatively, it can also be pregnancy tests, spectacles, wheelchairs and hearing aids. Meanwhile, Visual 1: at Diversity the high-tech and end classification of the scale, medical of medical technology technology includes molecular diagnostics, total Medical body scanners, Devices ultrasounds, life-supporting machines, implantable devices such as heart valves In Vitro and pacemakers, Diagnostics neurostimulators and replacement joints for knees and hips. The common thread through all applications of medical technology is the beneficial impact on health, quality of life and in society as a whole. Medical technologies contribute to living longer and better, and empower citizens to contribute to society for longer. In so doing, they improve the quality of care and the efficacy, efficiency and sustainability of healthcare systems. 6 What is Medical Technology?

Regulation and classification of medical technologies In the European Union, medical technologies are tightly regulated by laws that govern the safety and performance of devices across their lifetime, pre- and post-market. Over the next few years, the European medical technology sector will transition from being regulated under the current medical devices directives to two new regulations. What is Medical Technology? 7

Classification of in vitro diagnostic medical devices Today, the in vitro diagnostic (IVD) sector is regulated by Directive 98/79/EC. From 26 May 2022, the new Regulation 2017/746/EU will fully apply. Until this date, manufacturers can choose to comply with either the Directive or the Regulation. Classification of IVDs is important as it determines the level of involvement by a third party (the notified body ) in assessing IVDs both pre- and post-market. This level of control is generally relative to the risk of an erroneous result from the assay. Under the IVD Directive, IVDs are classified into four classes following a positive list approach: Annex II List A Annex II List B Devices for self-testing Self-declared devices (e.g. ABO bloodtyping) (e.g. blood glucose monitoring) (e.g. pregnancy tests) (e.g. clinical chemistry analyser) Under the IVD Regulation, all IVDs will be classified under a new risk-based classification system according to the risk the device poses to the health of the public and or an individual as result of an incorrect test result. All IVDs will be classified under class A, B, C or D, with class D being the highest risk class. 8 What is Medical Technology?

Classification of medical devices The medical device (MD) sector is regulated by Directives 93/42/EC and 90/385/EEC. From 26 May 2020, the new Regulation 2017/745/EU will fully apply. Until this date, manufacturers can choose to comply with either the Directives or the Regulation. Classification of medical devices (estimated to be more than 500.000) drives many pre- and postmarket requirements. Due to the large variety of products, the level of control made by a thirdparty (the notified body ) before placing them in the market depends on the level of impact on the human body that their use might imply. The same notified body is involved post-market to ensure the continued safety and performance of medical devices. Under the MD Directive, MDs are classified into 4 classes following a risk based classification system: Class I Class IIa Class IIb Class III (e.g. simple bandages or wound care products) (e.g. syringes without the needle) (e.g. anaesthesia machines) (e.g. pacemakers) Under the new MD Regulation, the risk-based classification system contained in the current Directives has been maintained, although some changes/additions have been introduced. The principle is the same: to link the class of the device to the potential risk posed to the health of the public and an individual as result of fault in the functioning. All MDs are classified under class I, IIA, IIB or III, with class III being the highest risk class. What is Medical Technology? 9

Innovation

Medical technology is characterised by a constant flow of innovation, which is the result of a high level of research and development within the industry, and of close co-operation with the users. Products typically have a lifecycle of only 18-24 months before an improved product becomes available. In 2016, more than 12,200 patent applications were filed with the European Patent Office (EPO) in the field of medical technology 7.7% of the total number of applications, still more than any other sector in Europe. 41% of these patent applications were filed from European countries (EU28, Norway and Switzerland) and 59% from other countries, out of which with the majority of applications filed from the US (38%). In comparison, around 5,700 applications were filed in the pharmaceutical field and around 5,700 also in the field of biotechnology. While over the last decade the number of EPO filings in the field of medical technology has doubled, pharma and biotech patent applications were relatively stagnant 1. PATENT APPLICATION IN MEDICAL TECHNOLOGY FIELD FILLED WITH EPO IN 2016 41% EU28, Norway and Switzerland 59% Other countries Innovation 11

TOP 10 TECHNICAL FIELDS IN PATENT APPLICATIONS. NUMBER OF PATENT APPLICATIONS FILED WITH EPO, 2016 (REF. 1) 12,263 MEDICAL TECHNOLOGY 10,915 10,657 DIGITAL COMMUNICATION COMPUTER TECHNOLOGY 10,293 ELECTRICAL MACHINERY, APPARATUS, ENERGY 8,402 7,442 6,301 TRANSPORT MEASUREMENT ENGINES, PUMPS, TURBINES 6,189 5,754 5,744 ORGANIC FINE CHEMISTRY PHARMACEUTICALS BIOTECHNOLOGY

EVOLUTION OF EUROPEAN PATENT APPLICATIONS BY TECHNICAL FIELD (REF. 1) 14.000 12.000 10.000 8.000 6.000 4.000 2.000 0 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 Medical technology Biotechnology Pharmaceuticals Innovation 13

Employment

>675,000 3 employees The European medical technology industry employs directly more than 675,000 people. Germany had the highest absolute number of people employed in the medical technology sector, while the number of medtech employees per capita is highest in Ireland and Switzerland. This high level of employment shows that the medical technology industry is an important player in the European economy. In comparison, the European pharmaceutical industry employs more than 740,000 people 2. Europe refers to EU 28, Norway and Switzerland unless specified otherwise. Employment 15

TOP 7 COUNTRIES WITH HIGHEST EMPLOYMENT IN THE MEDICAL TECHNOLOGY INDUSTRY (REF. 3) United Kingdom 100,000 Germany 210,000 Ireland 35,000 Switzerland 54,000 France 85,000 Spain 23,000 Italy 38,000 16 MedTech Market in Europe

NUMBER OF PEOPLE DIRECTLY EMPLOYED IN THE MEDICAL TECHNOLOGY INDUSTRY PER 10,000 INHABITANTS IN 2016 (REF. 3) Ireland 74 Switzerland 64 Denmark 26 Germany 25 Sweden 23 Belgium 15 UK 15 France 13 Italy 13 Netherlands 9 Spain 5 Greece 5 Portugal 4 Employment 17

Companies

27,000 medical technology companies in Europe 95% SMEs There are approximately 27,000 medical technology companies in Europe. Most of them are based in Germany, followed by the UK, Italy, Switzerland, France and Spain. Small and medium-sized companies (SMEs*) make up almost 95% of the medical technology industry, the majority of which employ less than 50 people (small and micro-sized companies) 3. *An enterprise is considered to be a SME if it employs fewer than 250 persons and has an annual turnover not exceeding 50 million (small company- employs fewer than 50 persons and has a turnover of less than 10 million). Companies 19

Expenditure on Medical Technology

203 Expenditure on medical technology per capita in Europe In Europe, an average of 10% of gross domestic product (GDP) is spent on healthcare. Of this figure, around 7.2% is attributed to medical technologies, i.e. less than 1% of GDP. The spending on medical technology is estimated to vary significantly across European countries, ranging from around 5% to 10% of the total healthcare expenditure 4. Expenditure on medical technology per capita in Europe is at around 203 (weighted average). Expenditure on Medical Technology 21

BREAKDOWN OF TOTAL HEALTHCARE EXPENDITURE IN EUROPE (REF. 5) 7.2% Medical technology 0.7% In vitro diagnostics 15.9% Phamaceuticals & other medical non-durables 6.5% Medical devices (incl. imaging) 76.9% Inpatient & outpatient care, other 22 Expenditure on Medical Technology

Expenditure on Medical Technology 23

MedTech Market in Europe

110 billion market The European medical technology market in 2016 is estimated at roughly 110 billion 6. Based upon manufacturer prices the European medical technology market is estimated to make up 29% of the world market. It is the second largest medical technology market after the US (approximately 43%). MedTech Market in Europe 25

EUROPEAN MEDICAL DEVICE MARKET BY COUNTRY, BASED UPON MANUFACTURER PRICES, 2016 (REF. 6) GERMANY 28 % FRANCE 15 % UK 12 % ITALY 10 % SPAIN 6 % NETHERLANDS 4 % SWITZERLAND 4 % BELGIUM 3 % SWEDEN 2 % AUSTRIA 2 % OTHER 14 % 26 MedTech Market in Europe The biggest medtech markets in Europe are Germany, France, the United Kingdom, Italy and Spain 6. The same countries form the top 5 IVD markets in Europe 7.

EUROPEAN IVD MARKET BY COUNTRY, 2016 (REF. 7) GERMANY 21 % ITALY 15 % FRANCE 13 % SPAIN 9 % UK 9 % SWITZERLAND 4 % BELGIUM 3 % NETHERLANDS 3 % POLAND 3 % AUSTRIA 2 % OTHERS 17 % MedTech Market in Europe 27

WORLD MEDICAL DEVICE MARKET BY REGION BASED UPON MANUFACTURER PRICES, 2016 (REF. 6) USA EUROPE JAPAN CHINA 43 % 29 % 7 % 6 % CANADA BRAZIL RUSSIA OTHER 2 % 1 % 1 % 11 % 28 MedTech Market in Europe

WORLD MEDICAL TECHNOLOGY MARKET BY AREA AND SALES GROWTH, 2016-2022 (REF. 8) WW Market Share in 2022 18% 16% 14% 12% 10% 8% 6% 4% 2% 0% Diagnostic imaging Orthopedics Wound management Cardiology Ophthalmics Drug delivery General & Plastic Surgery Dental In Vitro Diagnostics (IVD) Endoscopy +3.0% +3.5% +4.0% +4.5% +5.0% +5.5% +6.0% +6.5% +7.0% Source: Evaluate, September 2017 % Sales Growth: CAGR 2016-22 Medical technology offers solutions for many disease areas. On a worldwide perspective, in vitro diagnostics are the largest sector, followed by cardiology and diagnostic imaging 8. Note: Size of Bubble = WW Sales in 2022 MedTech Market in Europe 29

EUROPEAN MEDICAL DEVICE MARKET GROWTH RATES, BASED UPON MANUFACTURER PRICES, 2008-2016 (REF. 6) 15% 10% 5% 0% 2008 2009 2010 2011 2012 2013 2014 2015 2016-5% The European medical technology market has been growing on average by 4,4% per annum over the past 9 years. Demand fell in 2009 due to the economic crisis, resulting in a growth rate of only 1%. The market recovered in 2010, but growth rates fell back in 2011. 30 MedTech Market in Europe

EUROPEAN IN VITRO DIAGNOSTICS MARKET GROWTH RATES, BASED UPON MANUFACTURER PRICES, 2008-2016 (REF. 7) 5% 4% 3% 2% 1% 0% 2008 2009 2010 2011 2012 2013 2014 2015 2016-1% -2% -3% -4% The European IVD market growth has been slowing down until 2013, while annual growth rates in the pre-crisis period were at around 2-4%. In 2013 the European market started to recover and the annual growth rate in 2016 was around 1%. * Market size estimated in manufacturers prices, not including margins, such as value added in the wholesaling and retailing, transportation costs, some taxes included in the final price, etc. MedTech Market in Europe 31

Trade in Europe

17.5 billion Estimation of Europe s trade surplus in 2016 Europe has a positive medical technology trade* balance of 17.5 billion (2016) and this represents a more than twofold increase since 2006. In comparison, the US medical technology trade surplus is at 5 billion. Compared to 2012, the main European medtech trade partners remain the same: the US, China and Japan (Ref 6). *Trade section does not include in vitro diagnostics in the figures for medical technology. Trade in Europe 33

TOP EUROPEAN MEDICAL DEVICE EXPORT DESTINATIONS, 2016 (REF. 6) Russia 2.8% USA 36.9% China 10.3% Japan 5.4% India 1.9% Brazil 1.4% 34 Trade in Europe

TOP SUPPLIERS TO EUROPEAN MEDICAL DEVICE MARKET (IMPORTS), 2016 (REF. 6) Canada 3.0% USA 55.0% India 0,8% Singapore 2.0% China 10.0% Japan 5.0% Australia 4.0% Trade in Europe 35

EXPORT AND IMPORTS OF MEDICAL DEVICE BY COUNTRY 2016 (INCLUDING INTRA-COMMUNITY TRADE, MILLION EUROS) (REF. 6) MILLIONS 25.000 25.040 20.000 16.439 15.658 15.000 10.000 12.959 11.419 6.934 9.579 10.673 7.361 9.681 9.741 5000 2.045 4.015 5.284 3.494 5.360 2.459 2.174 2.008 1.278 1.573 809 1.437 3.942 1.433 1.560 1.299 1.641 1.021 972 0 GERMANY NETHERLANDS BELGIUM IRELAND SWITZERLAND FRANCE UNITED KINGDOM ITALY AUSTRIA DENMARK FINLAND SPAIN SWEDEN POLAND CZECH REPUBLIC 36 Trade in Europe

MEDICAL DEVICE TRADE BALANCE BY COUNTRY (INCLUDING INTRA-COMMUNITY TRADE, MILLION EUROS), 2016 (REF. 6) MILLIONS 10.000 8.628 8.601 8000 6000 5.566 4000 2000 0% -2000-4000 IRELAND GERMANY SWITZERLAND 2.698 1.840 765 NETHERLANDS BELGIUM FINLAND DENMARK HUNGARY 730 379 286 49 AUSTRIA CZECH REPUBLIC LITHUANIA 46 ESTONIA LATVIA -61 BULGARIA -63-127 SLOVENIA -196-203 SWEDEN CROATIA SLOVAKIA ROMANIA -260-342 POLAND -462-471 PORTUGAL GREECE NORWAY -604 ITALY UK -1.865-2.077-2.504 SPAIN FRANCE -2.807 Trade in Europe 37

About MedTech Europe

MedTech Europe is the European trade association representing the medical technology industry from diagnosis to cure. We represent In-Vitro Diagnostics and Medical Devices manufacturers operating in Europe. MedTech Europe s mission is to make innovative medical technology available to more people, while helping healthcare systems move towards a sustainable path. MedTech Europe promotes a balanced policy environment that helps the medical technology industry meet Europe s growing healthcare needs and expectations. We also promote medical technology s value for Europe through our five-year industry strategy, which focuses on valuebased innovations that support more sustainable healthcare systems. We use economic research to show the benefits of medical technology and we organise many initiatives to explain the value we bring to Europe. We bring stakeholders together to discuss trends, issues and opportunities. Each year we also organise the European MedTech Forum, the largest health and industry policy conference in Europe, to engage with stakeholders on common topics of interest. About MedTech Europe 39

References 1 European Patent Office, MedTech Europe calculations. Medical technology as defined by World Intellectual Property Organization (based on the WIPO IPC-Technology concordance as revised in August 2014). European countries refer to EU + Norway, Switzerland. Patents are attributed by the country of residence of the applicant. 2 EFPIA The Pharmaceutical Industry in Figures. Key Data 2017. Europe refers to EU + Norway, Switzerland. 3 MedTech Europe calculation based on the data obtained from National Associations of 12 countries for the latest year available. Europe refers to EU + Norway, Switzerland. 4 WHO Global Health expenditure Database, Eurostat, BMI Research, MedTech Europe calculations based on the data obtained from National Associations of 15 countries for the latest year available. 5 BMI Research, WHO, Eurostat, EFPIA, EDMA, MedTech Europe calculations. Europe refers to EU + Norway, Switzerland. 6 BMI Research, MedTech Europe calculations. Manufacturer prices. Medical technology excluding in vitro diagnostics. 7 MedTech Europe - European IVD Market Statistics Report 2016. 8 Worldwide Medtech Sales by EvaluateMedTech Device Area: Top 15 Categories & Total Market (2016 & 2022)- http://info.evaluategroup.com/mtwp2017-emf.html

MedTech Europe, 2017

www.medtecheurope.org